NPAS2 variant A genes were associated with a lower risk of prostate cancer (ratio = 0.5, 95% CI, 0.3.0-1.0) in men with mild insulin resistance when compared to men with the GG genotype. This evidence concerns the gene NPAS2 and prostate cancer.